Annual Cash & Cash Equivalents
$19.26 M
-$45.85 M-70.42%
December 31, 2024
Summary
- As of March 10, 2025, CDXS annual cash & cash equivalents is $19.26 million, with the most recent change of -$45.85 million (-70.42%) on December 31, 2024.
- During the last 3 years, CDXS annual cash & cash equivalents has fallen by -$97.53 million (-83.51%).
- CDXS annual cash & cash equivalents is now -87.08% below its all-time high of $149.12 million, reached on December 31, 2020.
Performance
CDXS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$19.26 M
-$18.19 M-48.56%
December 1, 2024
Summary
- As of March 10, 2025, CDXS quarterly cash and cash equivalents is $19.26 million, with the most recent change of -$18.19 million (-48.56%) on December 1, 2024.
- Over the past year, CDXS quarterly cash and cash equivalents has stayed the same.
- CDXS quarterly cash and cash equivalents is now -87.08% below its all-time high of $149.12 million, reached on December 31, 2020.
Performance
CDXS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CDXS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.4% | 0.0% |
| 3 y3 years | -83.5% | 0.0% |
| 5 y5 years | -78.7% | 0.0% |
CDXS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -83.5% | at low | -83.5% | +3.6% |
| 5 y | 5-year | -87.1% | at low | -87.1% | +3.6% |
| alltime | all time | -87.1% | +0.1% | -87.1% | +38.4% |
Codexis Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $19.26 M(-70.4%) | - |
| Dec 2024 | - | $19.26 M(-48.6%) |
| Sep 2024 | - | $37.45 M(+101.4%) |
| Jun 2024 | - | $18.59 M(-68.0%) |
| Mar 2024 | - | $58.05 M(-10.9%) |
| Dec 2023 | $65.12 M(-42.9%) | $65.12 M(-12.7%) |
| Sep 2023 | - | $74.58 M(-19.0%) |
| Jun 2023 | - | $92.09 M(-10.4%) |
| Mar 2023 | - | $102.83 M(-9.8%) |
| Dec 2022 | $113.98 M(-2.4%) | $113.98 M(+4.9%) |
| Sep 2022 | - | $108.69 M(+20.6%) |
| Jun 2022 | - | $90.11 M(-4.4%) |
| Mar 2022 | - | $94.26 M(-19.3%) |
| Dec 2021 | $116.80 M(-21.7%) | $116.80 M(-2.0%) |
| Sep 2021 | - | $119.19 M(-8.0%) |
| Jun 2021 | - | $129.51 M(-7.3%) |
| Mar 2021 | - | $139.75 M(-6.3%) |
| Dec 2020 | $149.12 M(+64.8%) | $149.12 M(+108.5%) |
| Sep 2020 | - | $71.52 M(-5.5%) |
| Jun 2020 | - | $75.65 M(-13.4%) |
| Mar 2020 | - | $87.33 M(-3.5%) |
| Dec 2019 | $90.50 M(+70.6%) | $90.50 M(-1.8%) |
| Sep 2019 | - | $92.14 M(-1.4%) |
| Jun 2019 | - | $93.42 M(+97.4%) |
| Mar 2019 | - | $47.32 M(-10.8%) |
| Dec 2018 | $53.04 M(+69.9%) | $53.04 M(-2.2%) |
| Sep 2018 | - | $54.23 M(+1.1%) |
| Jun 2018 | - | $53.62 M(+120.7%) |
| Mar 2018 | - | $24.30 M(-22.2%) |
| Dec 2017 | $31.22 M(+62.3%) | $31.22 M(+31.0%) |
| Sep 2017 | - | $23.83 M(-17.3%) |
| Jun 2017 | - | $28.82 M(+107.0%) |
| Mar 2017 | - | $13.92 M(-27.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $19.24 M(-17.3%) | $19.24 M(+29.0%) |
| Sep 2016 | - | $14.92 M(-33.3%) |
| Jun 2016 | - | $22.35 M(+0.9%) |
| Mar 2016 | - | $22.16 M(-4.8%) |
| Dec 2015 | $23.27 M(-12.1%) | $23.27 M(+37.2%) |
| Sep 2015 | - | $16.96 M(+2.2%) |
| Jun 2015 | - | $16.60 M(-25.1%) |
| Mar 2015 | - | $22.16 M(-16.3%) |
| Dec 2014 | $26.49 M(+19.7%) | $26.49 M(+23.1%) |
| Sep 2014 | - | $21.52 M(+7.1%) |
| Jun 2014 | - | $20.09 M(-13.3%) |
| Mar 2014 | - | $23.16 M(+4.7%) |
| Dec 2013 | $22.13 M(-30.9%) | $22.13 M(-17.8%) |
| Sep 2013 | - | $26.91 M(-16.9%) |
| Jun 2013 | - | $32.39 M(+3.7%) |
| Mar 2013 | - | $31.23 M(-2.4%) |
| Dec 2012 | $32.00 M(+24.2%) | $32.00 M(+25.1%) |
| Sep 2012 | - | $25.57 M(+53.2%) |
| Jun 2012 | - | $16.69 M(-37.3%) |
| Mar 2012 | - | $26.60 M(+3.3%) |
| Dec 2011 | $25.76 M(-64.4%) | $25.76 M(-14.5%) |
| Sep 2011 | - | $30.13 M(-6.1%) |
| Jun 2011 | - | $32.08 M(-39.6%) |
| Mar 2011 | - | $53.15 M(-26.6%) |
| Dec 2010 | $72.40 M(+127.8%) | $72.40 M(-27.1%) |
| Sep 2010 | - | $99.27 M(+93.1%) |
| Jun 2010 | - | $51.41 M(+76.1%) |
| Mar 2010 | - | $29.20 M(-8.1%) |
| Dec 2009 | $31.79 M(+45.1%) | $31.79 M(+40.4%) |
| Sep 2009 | - | $22.64 M(+3.4%) |
| Dec 2008 | $21.90 M(-60.2%) | $21.90 M(-21.6%) |
| Mar 2008 | - | $27.93 M |
| Dec 2007 | $55.08 M(+70.8%) | - |
| Dec 2006 | $32.25 M | - |
FAQ
- What is Codexis annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Codexis?
- What is Codexis annual cash & cash equivalents year-on-year change?
- What is Codexis quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Codexis?
- What is Codexis quarterly cash and cash equivalents year-on-year change?
What is Codexis annual cash & cash equivalents?
The current annual cash & cash equivalents of CDXS is $19.26 M
What is the all time high annual cash & cash equivalents for Codexis?
Codexis all-time high annual cash & cash equivalents is $149.12 M
What is Codexis annual cash & cash equivalents year-on-year change?
Over the past year, CDXS annual cash & cash equivalents has changed by -$45.85 M (-70.42%)
What is Codexis quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CDXS is $19.26 M
What is the all time high quarterly cash and cash equivalents for Codexis?
Codexis all-time high quarterly cash and cash equivalents is $149.12 M
What is Codexis quarterly cash and cash equivalents year-on-year change?
Over the past year, CDXS quarterly cash and cash equivalents has changed by $0.00 (0.00%)